In the perspective of 10–20 years, the ophthalmic care system in Poland will face numerous challenges, and the existing problems will increase. Due to the aging of the population, the incidence of refractive errors and chronic, age-related diseases such as presbyopia, AMD, diabetic retinopathy, glaucoma and cataracts will increase. Due to the change in lifestyle, the incidence of myopia is expected to increase among children and adolescents. The number of ophthalmologists and nurses will decrease and the average age of these professional groups will increase. The number of optometrists in Poland is low, and the legal aspects of practicing the profession of optometrists remain unregulated. Low social awareness contributes to late detection of eye diseases, which worsens the prognosis and increases the costs of treatment.
{"title":"Selected problems and challenges of ophthalmic care system in Poland","authors":"M. Osęka, A. Jamrozy-Witkowska, M. Mulak","doi":"10.24292/01.OT.300321.2","DOIUrl":"https://doi.org/10.24292/01.OT.300321.2","url":null,"abstract":"In the perspective of 10–20 years, the ophthalmic care system in Poland will face numerous challenges, and the existing problems will increase. Due to the aging of the population, the incidence of refractive errors and chronic, age-related diseases such as presbyopia, AMD, diabetic retinopathy, glaucoma and cataracts will increase. Due to the change in lifestyle, the incidence of myopia is expected to increase among children and adolescents. The number of ophthalmologists and nurses will decrease and the average age of these professional groups will increase. The number of optometrists in Poland is low, and the legal aspects of practicing the profession of optometrists remain unregulated. Low social awareness contributes to late detection of eye diseases, which worsens the prognosis and increases the costs of treatment.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122685003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: The aim of the article was to discuss the role of balanced supplementation in diet of age-related macular degeneration patients. Methods: This review was carried out using comprehensive and systematic literature reports on the role of supplementation of vitamin D, vitamin C, vitamin E, vitamin B6, vitamin B12, zinc, lutein, zeaxanthin, omega-3 acid and folic acid in the prevention of AMD. Results: Vitamins, minerals and carotenoids are essential for the proper retinal function over an inflammation and immune response modulation. Conclusions: Vitamins, minerals and carotenoids discussed in the article have anti-inflammatory and antioxidative properties in the management of AMD progression. Accordingly, it is relevant to assure the appropriate level of these nutrients in a diet of AMD patients.
{"title":"The role of balanced supplementation in diet of age-related macular degeneration patients","authors":"Iwona Kusz vel Sobczuk, Anna Święch","doi":"10.24292/01.ot.300321.1","DOIUrl":"https://doi.org/10.24292/01.ot.300321.1","url":null,"abstract":"Aim: The aim of the article was to discuss the role of balanced supplementation in diet of age-related macular degeneration patients. \u0000Methods: This review was carried out using comprehensive and systematic literature reports on the role of supplementation of vitamin D, vitamin C, vitamin E, vitamin B6, vitamin B12, zinc, lutein, zeaxanthin, omega-3 acid and folic acid in the prevention of AMD. \u0000Results: Vitamins, minerals and carotenoids are essential for the proper retinal function over an inflammation and immune response modulation. \u0000Conclusions: Vitamins, minerals and carotenoids discussed in the article have anti-inflammatory and antioxidative properties in the management of AMD progression. Accordingly, it is relevant to assure the appropriate level of these nutrients in a diet of AMD patients.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117251705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Urszula Michalik-Marcinkowska, Ilona Jas, Andrzej Misiak, D. Dobrowolski
Zwyrodnienie plamki związane z wiekiem (AMD, age-related macular degeneration) to obecnie główna przyczyna obniżenia ostrości wzroku, a nawet ślepoty w populacji osób powyżej 45. r.ż. Postępowanie lecznicze w wysiękowej postaci AMD polega na jak najszybszym włączeniu terapii anty-VEGF w postaci iniekcji doszklistkowych. Od 2015 r. w Polsce jest dostępny program lekowy dla pacjentów z wysiękową postacią AMD. W ramach programu zatwierdzono preparaty ranibizumab oraz aflibercept. Celem badań była ocena skuteczności stosowania programu lekowego wśród pacjentów z wysiękową postacią AMD. Z zastosowaniem badań diagnostycznych oraz sondażu diagnostycznego przebadano 98 pacjentów biorących udział w programie lekowym.
{"title":"Program lekowy wysiękowego zwyrodnienia plamki związanego z wiekiem – efekty leczenia w oparciu o badania diagnostyczne i ocenę pacjentów","authors":"Urszula Michalik-Marcinkowska, Ilona Jas, Andrzej Misiak, D. Dobrowolski","doi":"10.24292/01.ot.311220.x","DOIUrl":"https://doi.org/10.24292/01.ot.311220.x","url":null,"abstract":"Zwyrodnienie plamki związane z wiekiem (AMD, age-related macular degeneration) to obecnie główna przyczyna obniżenia ostrości wzroku, a nawet ślepoty w populacji osób powyżej 45. r.ż. Postępowanie lecznicze w wysiękowej postaci AMD polega na jak najszybszym włączeniu terapii anty-VEGF w postaci iniekcji doszklistkowych. Od 2015 r. w Polsce jest dostępny program lekowy dla pacjentów z wysiękową postacią AMD. W ramach programu zatwierdzono preparaty ranibizumab oraz aflibercept. Celem badań była ocena skuteczności stosowania programu lekowego wśród pacjentów z wysiękową postacią AMD. Z zastosowaniem badań diagnostycznych oraz sondażu diagnostycznego przebadano 98 pacjentów biorących udział w programie lekowym.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128033669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-31DOI: 10.24292/01.OT.311220.11
J. Wasyluk, Ilona A Kaczmarek, R. Różycki
Selective laser trabeculoplasty (SLT) and micropulse laser trabeculoplasty (MLT) are well established, non-invasive laser procedures in glaucoma, but their place in the therapeutic algorithm still evolves. Lately published multicenter randomized clinical trials indicate the need to consider laser trabeculoplasty as the first-line treatment before medications in primary open-angle glaucoma an ocular hypertension due to its favorable safety profile, efficacy and cost-effectiveness. Subthreshold transscleral cyclophotocoagulation (present on the market under different brand names: SubCyclo® TS-CPC [Quantel, France] or Cyclo G6® mTS-CPC [Iridex, USA]) is an antiglaucomatous laser procedure, recently arousing more and more interest in ophthalmologists as a new non-invasive method in our therapeutic portfolio. This new device utilizes 810 nm diode laser beam, fractionated into ultra-short pulses, resulting in low energy spots without causing ciliary body coagulation. Subthreshold (or subliminal) energy delivered during the session spares the tissue due to very limited local heat accumulation zone and therefore this procedure may be repeated. Laser energy partially disables aqueous producing ciliary epithelium and opens supraciliary space thus activating the additional outflow facility. Subthreshold TS-CPC in several clinical trials proved to be effective in lowering the intraocular pressure and devoid of significant sight threatening side effects, comparing to the classical thermal diode cyclophotocoagulation method.
{"title":"Laser trabeculoplasty and subthreshold transscleral cyclophotocoagulation – the new therapeutic options are modifying therapeutic algorithm in glaucoma","authors":"J. Wasyluk, Ilona A Kaczmarek, R. Różycki","doi":"10.24292/01.OT.311220.11","DOIUrl":"https://doi.org/10.24292/01.OT.311220.11","url":null,"abstract":"Selective laser trabeculoplasty (SLT) and micropulse laser trabeculoplasty (MLT) are well established, non-invasive laser procedures in glaucoma, but their place in the therapeutic algorithm still evolves. Lately published multicenter randomized clinical trials indicate the need to consider laser trabeculoplasty as the first-line treatment before medications in primary open-angle glaucoma an ocular hypertension due to its favorable safety profile, efficacy and cost-effectiveness. Subthreshold transscleral cyclophotocoagulation (present on the market under different brand names: SubCyclo® TS-CPC [Quantel, France] or Cyclo G6® mTS-CPC [Iridex, USA]) is an antiglaucomatous laser procedure, recently arousing more and more interest in ophthalmologists as a new non-invasive method in our therapeutic portfolio. This new device utilizes 810 nm diode laser beam, fractionated into ultra-short pulses, resulting in low energy spots without causing ciliary body coagulation. Subthreshold (or subliminal) energy delivered during the session spares the tissue due to very limited local heat accumulation zone and therefore this procedure may be repeated. Laser energy partially disables aqueous producing ciliary epithelium and opens supraciliary space thus activating the additional outflow facility. Subthreshold TS-CPC in several clinical trials proved to be effective in lowering the intraocular pressure and devoid of significant sight threatening side effects, comparing to the classical thermal diode cyclophotocoagulation method.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"163 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120995958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Prof. dr hab. n. med. Ariadna Gierek-Łapińska (1938–2020)
阿里亚德娜-吉雷克-罗皮恩斯卡教授（1938-2020）博士
{"title":"Prof. dr hab. n. med. Ariadna Gierek-Łapińska (1938–2020)","authors":"Marek E. Prost","doi":"10.24292/01.ot.311220.z","DOIUrl":"https://doi.org/10.24292/01.ot.311220.z","url":null,"abstract":"Prof. dr hab. n. med. Ariadna Gierek-Łapińska (1938–2020)","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127013888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-12-31DOI: 10.24292/01.ot.311219.07
Katarzyna Przekoracka, K. Michalak, A. Michalski, Jan Olszewski, Joanna Paluch, A. Przekoracka-Krawczyk
The aim of the present study was to assess whether soft multifocal contact lens (SMFCLs) with high addition powers, designed for myopia control, may have an impact on eye movements and eye–hand coordination. A total of 24 young adults used SMFCLs (Relax, SwissLens) with high additions: +2D (Add2) and +4D (Add4). Single vision (Add0) contact lenses were used as controls (Orbis, SwissLens). In the eye–hand coordination task, the study participants were asked to point out the small circle displayed on a touch screen. Reaction time and accuracy of pointing, as well as latency of eye movements were measured. Results showed that SMFCLs had no significant impact on the latency of eye movements (135, 136, 139 ms, for Add0, Add2 and Add4, p = 0.171), reaction time (732, 730, 727 ms for Add0, Add2 and Add4, p = 0.932) or percent error (17%, 13%, 18% for Add0, Add2 and Add4, p = 0.386).
本研究的目的是评估用于近视控制的高附加倍率软多焦隐形眼镜(SMFCLs)是否会影响眼球运动和眼手协调。共有24名年轻人使用了高添加量的smfcl (Relax, SwissLens): +2D (Add2)和+4D (Add4)。单视力(Add0)隐形眼镜作为对照(Orbis, SwissLens)。在手眼协调任务中，研究参与者被要求指出触摸屏上显示的小圆圈。测量了反应时间、指向的准确性以及眼球运动的潜伏期。结果表明，SMFCLs对眼球运动潜伏期(Add0、Add2和Add4分别为135、136、139 ms, p = 0.171)、反应时间(Add0、Add2和Add4分别为732、730、727 ms, p = 0.932)和误差百分比(Add0、Add2和Add4分别为17%、13%、18%，p = 0.386)均无显著影响。
{"title":"The influence of soft multifocal contact lenses with high additions on the eye–hand coordination","authors":"Katarzyna Przekoracka, K. Michalak, A. Michalski, Jan Olszewski, Joanna Paluch, A. Przekoracka-Krawczyk","doi":"10.24292/01.ot.311219.07","DOIUrl":"https://doi.org/10.24292/01.ot.311219.07","url":null,"abstract":"The aim of the present study was to assess whether soft multifocal contact lens (SMFCLs) with high addition powers, designed for myopia control, may have an impact on eye movements and eye–hand coordination. A total of 24 young adults used SMFCLs (Relax, SwissLens) with high additions: +2D (Add2) and +4D (Add4). Single vision (Add0) contact lenses were used as controls (Orbis, SwissLens). In the eye–hand coordination task, the study participants were asked to point out the small circle displayed on a touch screen. Reaction time and accuracy of pointing, as well as latency of eye movements were measured. Results showed that SMFCLs had no significant impact on the latency of eye movements (135, 136, 139 ms, for Add0, Add2 and Add4, p = 0.171), reaction time (732, 730, 727 ms for Add0, Add2 and Add4, p = 0.932) or percent error (17%, 13%, 18% for Add0, Add2 and Add4, p = 0.386).","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115479797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-30DOI: 10.24292/01.ot.300919.01
A. Grzybowski, K. Kupidura-Majewski
Postoperative endophthalmitis after cataract surgery, although very rare, remains an important cause of blindness. Practice patterns vary in many European countries. They include topical antibiotics before surgery, use of povidone-iodine, intracameral antibiotics at the end of the procedure, subconjunctival injection, use of topical antibiotics after surgery, and also emerging ideas such as dropless cataract surgery. The purpose of this article is to present the current management strategy and the role of local antibiotic therapy used in the prevention of endophthalmitis.
{"title":"The role of topical antibiotics in perioperative endophthalmitis prevention in cataract surgery","authors":"A. Grzybowski, K. Kupidura-Majewski","doi":"10.24292/01.ot.300919.01","DOIUrl":"https://doi.org/10.24292/01.ot.300919.01","url":null,"abstract":"Postoperative endophthalmitis after cataract surgery, although very rare, remains an important cause of blindness. Practice patterns vary in many European countries. They include topical antibiotics before surgery, use of povidone-iodine, intracameral antibiotics at the end of the procedure, subconjunctival injection, use of topical antibiotics after surgery, and also emerging ideas such as dropless cataract surgery. The purpose of this article is to present the current management strategy and the role of local antibiotic therapy used in the prevention of endophthalmitis.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125755132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-30DOI: 10.24292/01.ot.300919.05
J. Wasyluk, I. Kaczmarek, M. Strąk, M. Myślińska, Marta Dubisz
{"title":"Zastosowanie generatora plazmowego w zabiegach okuloplastycznych – doświadczenia własne","authors":"J. Wasyluk, I. Kaczmarek, M. Strąk, M. Myślińska, Marta Dubisz","doi":"10.24292/01.ot.300919.05","DOIUrl":"https://doi.org/10.24292/01.ot.300919.05","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134284355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-30DOI: 10.24292/01.ot.300919.06
M. Prost
Background: Since pediatric ophthalmologists still prefer to implant monofocal IOL and experience with multifocal IOL implantation in children is limited. Therefore, the aim of the study was to evaluate visual results after bilateral implantation of multifocal versus monofocal IOLs in children aged 1–5 years with congenital cataract. Methods: Children between 1 and 5 years of age with bilateral cataract who underwent cataract removal implantation of an multifocal IOL – Lentis Mplusx, Oculentis GmbH, Germany (55 children – group A) or monofocal IOL – C-flex Aspheric Monofocal, Rayner Intraocular Lenses Limited, UK (55 children – group B). The distance corrected visual acuity, distance corrected near visual acuity, binocular function using the Worth 4-dot test, stereopsis using the TNO test were evaluated. Results: At the final follow-up visit after 12 months, the mean best corrected distant visual acuity was not significantly different between groups A and B but the best corrected near visual acuity, binocular vision and stereopsis were significantly better in patients from group A as compared to group B. Conclusion: Implantation of a multifocal IOL in children aged 1–5 years with bilateral cataract provides a better level of near vision and considerably improves the development of stereopsis in comparison with children after monofocal IOL implantation.
{"title":"Visual function after bilateral implantation of multifocal versus monofocal IOLs in children below 5 years of age","authors":"M. Prost","doi":"10.24292/01.ot.300919.06","DOIUrl":"https://doi.org/10.24292/01.ot.300919.06","url":null,"abstract":"Background: Since pediatric ophthalmologists still prefer to implant monofocal IOL and experience with multifocal IOL implantation in children is limited. Therefore, the aim of the study was to evaluate visual results after bilateral implantation of multifocal versus monofocal IOLs in children aged 1–5 years with congenital cataract. Methods: Children between 1 and 5 years of age with bilateral cataract who underwent cataract removal implantation of an multifocal IOL – Lentis Mplusx, Oculentis GmbH, Germany (55 children – group A) or monofocal IOL – C-flex Aspheric Monofocal, Rayner Intraocular Lenses Limited, UK (55 children – group B). The distance corrected visual acuity, distance corrected near visual acuity, binocular function using the Worth 4-dot test, stereopsis using the TNO test were evaluated. Results: At the final follow-up visit after 12 months, the mean best corrected distant visual acuity was not significantly different between groups A and B but the best corrected near visual acuity, binocular vision and stereopsis were significantly better in patients from group A as compared to group B. Conclusion: Implantation of a multifocal IOL in children aged 1–5 years with bilateral cataract provides a better level of near vision and considerably improves the development of stereopsis in comparison with children after monofocal IOL implantation.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128059182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：